CE Credit Information

*Please note that the deadline for claiming credit for this activity has passed.

Fundamentals and Laser Safety: Core Principles for Clinical Applications
Orlando, FL
April 23, 2025

Maximum Credits:
8.0 / AMA PRA Category 1 Credit™
8.0 / ANCC Contact Hours
9.4 / Contact Hours (CBRN)

Activity Overview

This session will cover the following topics: Basic Principles of Lasers and related technologies & Laser Safety, Laser Endpoints, Laser for Tattoos and Pigmented Lesions, Laser for Follicular Conditions: Hair Removal, Acne etc, Laser Treatment of Vascular Conditions, Non-Ablative resurfacing and skin tightening, Fractional and Full Ablative Laser Resurfacing, Laser Resurfacing in Darker Skin types, Laser Assisted drug Delivery, Laser treatment of scars, Combination Therapy, Laser Complications, Clinical Laser Pearls for treatment of Skin of Color, Laser pearls and Common conditions, Laser Practice for Beginners: Setting up a pathway to success.

Target Audience

This activity is designed for an audience of physicians and other healthcare professionals interested in dermatology and aesthetics looking to expand their knowledge of laser technologies, safety, and treatments for a wide range of skin conditions, including hair removal, acne, and vascular concerns.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

Describe how to apply the principles of laser-tissue interactions.
Explain how to choose the appropriate technology for the treatment of different medical conditions.
Identify laser therapeutic and warning endpoints.
Summarize best practices for using lasers.

Criteria for Success

A certificate of completion will be awarded based on the participant's attendance. A certificate of completion will be available upon completion of an online evaluation/claim credit form available at: https://www.akhcme.com/aslms/. Please claim your credit by 2:00 PM EDT on May 28, 2025. If you have questions about this CE activity, please contact AKH Inc at tbrignoni@akhcme.com.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American Society for Laser Medicine and Surgery, Inc. (ASLMS). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Credit being awarded: 8.0 ANCC contact hours

California Board of Registered Nursing

In compliance with the Professional Medical Education Association which is accredited with the California Board of Registered Nursing, Provider # CEP 12386, CE Credit hours are calculated as 1 contact hour per 50 minutes of instruction. Courses must not be less than 60 minutes in length and attendees may not claim partial credit.

Commercial Support

There is no commercial support for this activity.

Disclosures

Disclosures All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Christine C. Dierickx, MD, discloses the following financial relationships: Consulting (e.g., advisory boards) Accure
Merete Haedersdal, MD, PhD, DMSc, discloses the following financial relationships: Consultant - Procter & Gamble; Contracted Research - La Roche-Posay - L'Oreal, Leo Pharma, Venus Concept; Equipment - Cynosure-Lutronic, GME Medical; Research collaboration - Damae, Michelson Diagnostics; Honoraria – Galderma
Omar A. Ibrahimi, MD, PhD, discloses the following financial relationships: Board of Director Blueberry Therapeutics; Consulting Fees (e.g., advisory boards) - AbbVie, Accure Acne, Blueberry Therapeutics, Cutera, Cytrellis, Lutronic, Organogenesis, Quthero; Medical Director - Lutronic; Stock Shareholder - AbbVie, Accure Acne, Anthem, AVAVA Medical, Beam Therapeutics, Blueberry Therapeutics, Crisper Therapeutics, Cutera, Editas, General Electric, Ginkgo Bioworks Holdings, Intellia, Johnson & Johnson, Moderna, Pfizer, Procter & Gamble, Quthero, Regeneron Pharmaceutical, Revance, Unilever, Vertex, Viatris
Fernanda H Sakamoto, MD, PhD, discloses the following financial relationships: Consulting (e.g., advisory boards) - Accure Acne, Inc., Beiersdorf; Owner/Co-Owner Founder/Co-Founder - Lightwater Bioscience ltd
Jill S Waibel, MD, discloses the following financial relationships: Advisory Board - Cytrellis Biosystems; Clinical Trial - Candela; Consulting Fees - Allergan, Candela, Cytrellis Biosystems, Galderma, Loreal, Lumenis, Procter & Gamble, RegenX, Sciton, Skinceuticals, Solta, VivoSight; Contracted Research - Amgen, Bellamia, Bristol Meyers Squibb, Cytrellis Biosystems, Eli Lilly, Emblation, Galderma, Horizon, Incyte, Janssen/JNJ, Loreal, Neuronetics, Pfizer, RegenX, Sanofi Shanghi Biopharma, PWB, Skinceuticals, VivoSight; Speakers' Bureau - Eli Lilly; VA Merit Grant

All the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH and ASLMS planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.

* Please note the agenda, faculty, and CE hours are subject to change.